News Release

CME Group Receives DOJ Clearance for Proposed NEX Acquisition

Fri Oct 12 2018

CHICAGO and LONDON, Oct. 12, 2018 /PRNewswire/ -- CME Group (Nasdaq: CME), the world's leading and most diverse derivatives marketplace, today announced that it has received clearance under the Hart-Scott-Rodino Act from the United States Department of Justice – Antitrust Division for its proposed acquisition of NEX Group plc (NXG.L).

CME and NEX have also received the relevant regulatory approvals from the FCA and regulators in the United States, Germany, Italy and Sweden, and have made the requisite pre-notifications in Hong Kong. Completion of the transaction remains subject to satisfaction or waiver of the remaining closing conditions, including competition clearance from the UK Competition and Markets Authority and the sanctioning of the transaction by the U.K. Court. The parties still expect the closing to occur by year end 2018.

About CME Group
As the world's leading and most diverse derivatives marketplace, CME Group (www.cmegroup.com) is where the world comes to manage risk.  CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest ratesequity indexesforeign exchangeenergyagricultural products and metals.  Around the world, CME Group brings buyers and sellers together through its CME Globex® electronic trading platform.  CME Group also operates one of the world's leading central counterparty clearing providers through CME Clearing, which offers clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives.  CME Group products and services ensure that businesses around the world can effectively manage risk and achieve growth.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex and E-mini are trademarks of Chicago Mercantile Exchange Inc.  CBOT, Chicago Board of Trade, KCBT and Kansas City Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc.  Dow Jones, Dow Jones Industrial Average, S&P 500 and S&P are service and/or trademarks of Dow Jones Trademark Holdings LLC, Standard & Poor's Financial Services LLC and S&P/Dow Jones Indices LLC, as the case may be, and have been licensed for use by Chicago Mercantile Exchange Inc.  All other trademarks are the property of their respective owners. 

About NEX
NEX offers customers better ways to execute trades and manage risk. Our products and services underpin the entire trade lifecycle pre-, during and post-execution. Our electronic trading platforms are industry standards. Customers use our lifecycle management and information services to optimise portfolios, control risk and reduce costs. We partner with emerging technology companies to bring greater efficiency, transparency and scale to the world's capital markets. NEX is headquartered in London with offices worldwide. NEX. Empowering markets.  For more information, go to www.nex.com.

Forward looking statements

This Press Release contains certain forward-looking statements with respect to CME Group, NEX and the combined company.  These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts.  Forward-looking statements often use words such as "anticipate", "target", "expect", "estimate", "intend", "plan", "goal", "believe", "aim", "will", "may", "would", "could" or "should" or other words of similar meaning or the negative thereof.  Forward-looking statements include statements relating to the expected closing of CME Group's proposed acquisition of NEX.

These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual timing of the closing to be materially different from the timing expressed or implied by such forward-looking statements.  These forward-looking statements are based largely on the expectations of CME Group and NEX and are subject to a number of risks and uncertainties, principally among them the ability to obtain required regulatory and court approvals and satisfy the other closing conditions on a timely basis, or at all.

All subsequent oral or written forward-looking statements attributable to CME Group, NEX, the combined company or any persons acting on their behalf are expressly qualified in their entirety by the cautionary statement above. Neither CME Group nor NEX undertakes any obligation to update publicly or revise forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.

The form 10-K of CME Group for the year ended December 31, 2017 contains additional information regarding forward-looking statements with respect to CME Group.

CME-G

 

SOURCE CME Group

CME Group, John Peschier, john.peschier@cmegroup.com, Investor Relations +1 312 930 8491; Anita Liskey, anita.liskey@cmegroup.com, Media Relations +1 312 466 4613; Laurie Bischel, laurie.bischel@cmegroup.com, Media Relations +1 312 648 8698; NEX, Alex Dee, Alex.Dee@nex.com, Investor Relations +44 207 050 7420; Bryony Bushnell, Bryony.Bushnell@nex.com, Media Relations +44 207 818 9689

Corporate Communications

+1 312 930 3434
Email